Last 12 months
Inside the activity.
1 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2026 Filed Mar 31, 2026 16:05 UTC |
Ackerman JohnDirector
|
Exercise / conversionClass A Common Stock | 1,413,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134488 · ownership.xml · nonDerivative · entry 1 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Pharmacy Investors, LLC Disclosed balance after: 2,449,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:05 UTC |
Salentine Thomas J JrDirector · 10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 6,100,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134494 · ownership.xml · derivative · entry 3 Salentine Thomas J Jr · CIK 0002037899 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 6,100,175 Underlying: Class A Common Stock · 6,100,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:05 UTC |
Salentine Thomas J JrDirector · 10% owner
|
Exercise / conversionClass A Common Stock | 6,100,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134494 · ownership.xml · nonDerivative · entry 1 Salentine Thomas J Jr · CIK 0002037899 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 10,569,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:05 UTC |
Cardinal Equity Fund, L.P.Member of 10% owner group
|
Exercise / conversionClass B Common Stock · Derivative | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134495 · ownership.xml · derivative · entry 2 Cardinal Equity Fund, L.P. · CIK 0001432819 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,057 Underlying: Class A Common Stock · 471,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:05 UTC |
Cardinal Equity Fund, L.P.Member of 10% owner group
|
Exercise / conversionClass A Common Stock | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134495 · ownership.xml · nonDerivative · entry 1 Cardinal Equity Fund, L.P. · CIK 0001432819 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 20:05 UTC |
Pharmacy Investors, LLCMember of 10% owner group
|
Exercise / conversionClass B Common Stock · Derivative | 1,413,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134500 · ownership.xml · derivative · entry 2 Pharmacy Investors, LLC · CIK 0002038519 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,413,939 Underlying: Class A Common Stock · 1,413,939 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 20:05 UTC |
Pharmacy Investors, LLCMember of 10% owner group
|
Exercise / conversionClass A Common Stock | 1,413,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-134500 · ownership.xml · nonDerivative · entry 1 Pharmacy Investors, LLC · CIK 0002038519 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,449,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
BINDLEY WILLIAM EDirector · 10% owner
|
SaleClass A Common Stock | 3,570,677 | $29.68 | $105,986,620.05 |
DisclosureSEC source: 0001193125-26-121838 · ownership.xml · nonDerivative · entry 1 BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 4,469,316 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Forbes KendallSee Remarks
|
SaleClass A Common Stock | 346,672 | $29.68 | $10,290,091.64 |
DisclosureSEC source: 0001193125-26-121836 · ownership.xml · nonDerivative · entry 1 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,256 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Bindley Capital Partners I, LLC10% owner
|
SaleClass A Common Stock | 3,570,677 | $29.68 | $105,986,620.05 |
DisclosureSEC source: 0001193125-26-121841 · ownership.xml · nonDerivative · entry 1 Bindley Capital Partners I, LLC · CIK 0002038820 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,469,316 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Salentine Thomas J JrDirector · 10% owner
|
SaleClass A Common Stock | 3,570,677 | $29.68 | $105,986,620.05 |
DisclosureSEC source: 0001193125-26-121842 · ownership.xml · nonDerivative · entry 1 Salentine Thomas J Jr · CIK 0002037899 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 4,469,316 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Morris David KDirector · See Remarks
|
SaleClass A Common Stock | 187,855 | $29.68 | $5,576,006.04 |
DisclosureSEC source: 0001193125-26-121845 · ownership.xml · nonDerivative · entry 1 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,472 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Burke FredDirector · See Remarks
|
SaleClass A Common Stock | 671,432 | $29.68 | $19,929,780.34 |
DisclosureSEC source: 0001193125-26-121843 · ownership.xml · nonDerivative · entry 1 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840,413 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Ackerman JohnDirector
|
SaleClass A Common Stock | 275,728 | $29.68 | $8,184,296.36 |
DisclosureSEC source: 0001193125-26-121839 · ownership.xml · nonDerivative · entry 2 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Cardinal Equity Fund, L.P. Disclosed balance after: 345,123 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Ackerman JohnDirector
|
SaleClass A Common Stock | 827,636 | $29.68 | $24,566,305.57 |
DisclosureSEC source: 0001193125-26-121839 · ownership.xml · nonDerivative · entry 1 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Pharmacy Investors, LLC Disclosed balance after: 1,035,928 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 16:15 UTC |
Cardinal Equity Fund, L.P.Member of 10% owner group
|
SaleClass A Common Stock | 275,728 | $29.68 | $8,184,296.36 |
DisclosureSEC source: 0001193125-26-121835 · ownership.xml · nonDerivative · entry 1 Cardinal Equity Fund, L.P. · CIK 0001432819 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,123 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:15 UTC |
Pharmacy Investors, LLCMember of 10% owner group
|
SaleClass A Common Stock | 827,636 | $29.68 | $24,566,305.57 |
DisclosureSEC source: 0001193125-26-121844 · ownership.xml · nonDerivative · entry 1 Pharmacy Investors, LLC · CIK 0002038519 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035,928 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:10 UTC |
Forbes KendallSee Remarks
|
GrantClass A Common Stock | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088191 · ownership.xml · nonDerivative · entry 1 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,928 F1 · shares: Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of Class A common stock, vesting in full on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:10 UTC |
Morris David KDirector · See Remarks
|
GrantClass A Common Stock | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088196 · ownership.xml · nonDerivative · entry 1 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,327 F1 · shares: Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of Class A common stock, vesting in full on March 1, 2029. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 16:05 UTC |
Forbes KendallSee Remarks
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001193125-26-051331 · ownership.xml · derivative · entry 1 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2036-02-11 F1 · derivative.exercise_date: This option shall vest and become exercisable in full on February 11, 2029. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 16:05 UTC |
Burke FredDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001193125-26-051327 · ownership.xml · derivative · entry 1 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2036-02-11 F1 · derivative.exercise_date: This option shall vest and become exercisable in full on February 11, 2029. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 16:05 UTC |
Morris David KDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001193125-26-051325 · ownership.xml · derivative · entry 1 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2036-02-11 F1 · derivative.exercise_date: This option shall vest and become exercisable in full on February 11, 2029. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 16:10 UTC |
Forbes KendallSee Remarks
|
GiftClass A Common Stock | 21,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311227 · ownership.xml · nonDerivative · entry 1 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 790,976 F1 · shares: Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the "DAF"). The DAF has agreed not to sell or transfer the shares during a lock-up period expiring June 30, 2026. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 16:10 UTC |
Burke FredDirector · See Remarks
|
GiftClass A Common Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311228 · ownership.xml · nonDerivative · entry 1 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,511,845 F1 · shares: Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the "DAF"). The DAF has agreed (i) not to sell or transfer the shares during a lock-up period expiring June 30, 2026, and (ii) to hold the shares in its account for up to three years from the gift date. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:10 UTC |
COSLER STEVEN DDirector
|
PurchaseClass A Common Stock | 3,370 | $29.61 | $99,785.70 |
DisclosureSEC source: 0001193125-25-309651 · ownership.xml · nonDerivative · entry 1 COSLER STEVEN D · CIK 0001187946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,984 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.31 to $29.80, inclusive. The Reporting Person undertakes to provide to Guardian Pharmacy Services, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
BINDLEY WILLIAM EDirector · 10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225029 · ownership.xml · derivative · entry 2 BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 12,200,350 Underlying: Class A Common Stock · 6,100,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
BINDLEY WILLIAM EDirector · 10% owner
|
Exercise / conversionClass A Common Stock | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225029 · ownership.xml · nonDerivative · entry 1 BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 8,039,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Forbes KendallSee Remarks
|
Exercise / conversionClass B Common Stock · Derivative | 608,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225034 · ownership.xml · derivative · entry 2 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,140 Underlying: Class A Common Stock · 608,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Forbes KendallSee Remarks
|
Exercise / conversionClass A Common Stock | 608,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225034 · ownership.xml · nonDerivative · entry 1 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Bindley Capital Partners I, LLC10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225031 · ownership.xml · derivative · entry 2 Bindley Capital Partners I, LLC · CIK 0002038820 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,200,350 Underlying: Class A Common Stock · 6,100,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Bindley Capital Partners I, LLC10% owner
|
Exercise / conversionClass A Common Stock | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225031 · ownership.xml · nonDerivative · entry 1 Bindley Capital Partners I, LLC · CIK 0002038820 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,039,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Burke FredDirector · See Remarks
|
Exercise / conversionClass B Common Stock · Derivative | 1,298,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225026 · ownership.xml · derivative · entry 2 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,597,651 Underlying: Class A Common Stock · 1,298,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Burke FredDirector · See Remarks
|
Exercise / conversionClass A Common Stock | 1,298,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225026 · ownership.xml · nonDerivative · entry 1 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,711,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Morris David KDirector · See Remarks
|
Exercise / conversionClass B Common Stock · Derivative | 641,869 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225028 · ownership.xml · derivative · entry 2 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,283,739 Underlying: Class A Common Stock · 641,869 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F3 · balance_after: Pursuant to the DRO, the Reporting Person has agreed to transfer an aggregate of 641,870 shares of Class A common stock (issuable upon the conversion of an equal number of shares of Class B common stock in accordance with its terms) to such former spouse during the period from March 28, 2026 through November 11,2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Morris David KDirector · See Remarks
|
Exercise / conversionClass A Common Stock | 641,869 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225028 · ownership.xml · nonDerivative · entry 1 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · balance_after: Pursuant to a September 2025 domestic relations order relating to an existing divorce settlement agreement with the Reporting Person's former spouse (the "DRO"), the Reporting Person has agreed to transfer an aggregate of 422,989 of these shares of Class A common stock to such former spouse by November 11, 2025. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Ackerman JohnDirector
|
Exercise / conversionClass B Common Stock · Derivative | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225035 · ownership.xml · derivative · entry 4 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Cardinal Equity Fund, L.P. Disclosed balance after: 942,114 Underlying: Class A Common Stock · 471,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Ackerman JohnDirector
|
Exercise / conversionClass B Common Stock · Derivative | 1,413,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225035 · ownership.xml · derivative · entry 3 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Pharmacy Investors, LLC Disclosed balance after: 2,827,878 Underlying: Class A Common Stock · 1,413,940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Ackerman JohnDirector
|
Exercise / conversionClass A Common Stock | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225035 · ownership.xml · nonDerivative · entry 2 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Cardinal Equity Fund, L.P. Disclosed balance after: 620,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Ackerman JohnDirector
|
Exercise / conversionClass A Common Stock | 1,413,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225035 · ownership.xml · nonDerivative · entry 1 Ackerman John · CIK 0002037898 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Pharmacy Investors, LLC Disclosed balance after: 1,863,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Salentine Thomas J JrDirector · 10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225030 · ownership.xml · derivative · entry 3 Salentine Thomas J Jr · CIK 0002037899 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 12,200,350 Underlying: Class A Common Stock · 6,100,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Salentine Thomas J JrDirector · 10% owner
|
Exercise / conversionClass A Common Stock | 6,100,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225030 · ownership.xml · nonDerivative · entry 1 Salentine Thomas J Jr · CIK 0002037899 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 8,039,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Cardinal Equity Fund, L.P.Member of 10% owner group
|
Exercise / conversionClass B Common Stock · Derivative | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225032 · ownership.xml · derivative · entry 4 Cardinal Equity Fund, L.P. · CIK 0001432819 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 942,114 Underlying: Class A Common Stock · 471,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · derivative.exercise_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · derivative.expiration_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 16:10 UTC |
Cardinal Equity Fund, L.P.Member of 10% owner group
|
Exercise / conversionClass A Common Stock | 471,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225032 · ownership.xml · nonDerivative · entry 3 Cardinal Equity Fund, L.P. · CIK 0001432819 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 20:10 UTC |
Pharmacy Investors, LLCMember of 10% owner group
|
Exercise / conversionClass B Common Stock · Derivative | 1,413,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225027 · ownership.xml · derivative · entry 4 Pharmacy Investors, LLC · CIK 0002038519 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,827,878 Underlying: Class A Common Stock · 1,413,940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · derivative.exercise_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. F2 · derivative.expiration_date: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| September 27, 2025 Filed Sep 30, 2025 20:10 UTC |
Pharmacy Investors, LLCMember of 10% owner group
|
Exercise / conversionClass A Common Stock | 1,413,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-225027 · ownership.xml · nonDerivative · entry 3 Pharmacy Investors, LLC · CIK 0002038519 · Member of 10% owner group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,863,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:15 UTC |
BINDLEY WILLIAM EDirector · 10% owner
|
SaleClass A Common Stock | 651,454 | $20.16 | $13,133,312.64 |
DisclosureSEC source: 0000950170-25-078973 · ownership.xml · nonDerivative · entry 2 BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Bindley Capital Partners I, LLC Disclosed balance after: 1,939,817 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:15 UTC |
Forbes KendallSee Remarks
|
SaleClass A Common Stock | 64,991 | $20.16 | $1,310,218.56 |
DisclosureSEC source: 0000950170-25-078968 · ownership.xml · nonDerivative · entry 2 Forbes Kendall · CIK 0002038507 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,906 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein. Read SEC document |
| May 28, 2025 Filed May 29, 2025 15:06 UTC |
Bindley Capital Partners I, LLC10% owner
|
SaleClass A Common Stock | 651,454 | $20.16 | $13,133,312.64 |
DisclosureSEC source: 0000950170-25-078856 · ownership.xml · nonDerivative · entry 2 Bindley Capital Partners I, LLC · CIK 0002038820 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,939,817 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:15 UTC |
Burke FredDirector · See Remarks
|
SaleClass A Common Stock | 138,705 | $20.16 | $2,796,292.80 |
DisclosureSEC source: 0000950170-25-078969 · ownership.xml · nonDerivative · entry 2 Burke Fred · CIK 0002037972 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,019 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:15 UTC |
Morris David KDirector · See Remarks
|
SaleClass A Common Stock | 68,547 | $20.16 | $1,381,907.52 |
DisclosureSEC source: 0000950170-25-078970 · ownership.xml · nonDerivative · entry 2 Morris David K · CIK 0002037977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,495 F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.